Discover
ADMA
ADMA Biologics, Inc.
8.61
2 x 6.26
3 x 8.82
bid
ask
+
0.24
2.87%
3 @ 05:52 AM
8.58 -0.03 (0.35%)
| Ytd | -52.80% | |
| 1y | -51.85% |
8.52
day range
8.76
7.21
52 week range
20.46
| Open | 8.56 | Prev Close | 8.37 | Low | 8.52 | High | 8.76 | Mkt Cap | 2.00B |
| Vol | 3.04M | Avg Vol | 5.26M | EPS | 0.68 | P/E | 12.66 | Forward P/E | 8.63 |
| Beta | 0.73 | Short Ratio | 6.37 | Inst. Own | 93.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.87 | 200-d Avg | 14.01 | 1yr Est | 17.60 |
| Income Statement | |||
| Total Revenue | 114.49M | ||
| Revenues (USD) | 114.49M | ||
| Cost of Revenue | 33.74M | ||
| Gross Profit | 80.75M | ||
| Operating Expenses | 22.48M | ||
| Research and Development Expense | 2.60M | ||
| Selling, General and Administrative Expense | 26.74M | ||
| Operating Income | 58.27M | ||
| Interest Expense | 2.10M | ||
| Income Tax Expense | 11.80M | ||
| Net Income | 45.33M | ||
| Net Income Common Stock | 45.33M | ||
| Net Income Common Stock (USD) | 45.33M | ||
| Consolidated Income | 45.33M | ||
| Earnings per Basic Share | 0.19 | ||
| Earnings per Basic Share (USD) | 0.19 | ||
| Earnings per Diluted Share | 0.19 | ||
| Earning Before Interest & Taxes (EBIT) | 59.23M | ||
| Earning Before Interest & Taxes (USD) | 59.23M | ||
| Weighted Average Shares | 236.07M | ||
| Weighted Average Shares Diluted | 239.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 138.15M | ||
| Cash and Equivalents (USD) | 138.15M | ||
| Trade and Non-Trade Receivables | 135.86M | ||
| Current Assets | 511.17M | ||
| Property, Plant & Equipment Net | 71.41M | ||
| Total Assets | 665.18M | ||
| Debt Current | 4.46M | ||
| Total Debt | 198.04M | ||
| Current Liabilities | 73.54M | ||
| Debt Non-Current | 193.58M | ||
| Total Liabilities | 274.86M | ||
| Accumulated Retained Earnings (Deficit) | -116.32M | ||
| Shareholders Equity | 390.33M | ||
| Shareholders Equity (USD) | 390.33M | ||
| Assets Non-Current | 154.01M | ||
| Total Debt (USD) | 198.04M | ||
| Deferred Revenue | 1.37M | ||
| Goodwill and Intangible Assets | 4.16M | ||
| Inventory | 222.10M | ||
| Liabilities Non-Current | 201.32M | ||
| Trade and Non-Trade Payables | 20.52M | ||
| Tax Assets | 69.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.84M | ||
| Net Cash Flow from Financing | -10.13M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 50.52M | ||
| Capital Expenditure | -2.54M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 5.00M | ||
| Issuance (Purchase) of Equity Shares | -129.60M | ||
| Issuance (Repayment) of Debt Securities | 124.53M | ||
| Net Cash Flow from Investing | 2.40M | ||
| Net Cash Flow from Operations | 58.25M | ||
| Share Based Compensation | 6.33M | ||